Globus Medical promotes Keith Pfeil to COO and CFO effective Feb 1, 2024

GLOBUS MEDICAL INC

Keith Pfeil adds COO role to his CFO responsibilities; effective February 1, 2024.
Base salary raised from $414,690 to $460,000; target bonus increased from $325,000 to $600,000.
Pfeil continues reporting to CEO Dan Scavilla; has been with Globus since August 2019.
Company expects to announce Q4 and full-year 2023 results on February 20, 2024.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Keith Pfeil

Chief Operating Officer and Chief Financial Officer

GMED · GLOBUS MEDICAL INC

Effective: 2024-02-01
Filed: February 5, 2024, 6:59 PM ET

On February 5, 2024, Globus Medical, Inc. (the “Company”) issued a news release announcing the promotion of Keith Pfeil to Chief Operating Officer and Chief Financial Officer, effective as of February 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Keith Pfeil changed role as Chief Operating Officer and Chief Financial Officer at GLOBUS MEDICAL INC.

Action: promoted
Role: Chief Operating Officer and Chief Financial Officer

Exact text from the filing

On February 5, 2024, Globus Medical, Inc. (the “Company”) issued a news release announcing the promotion of Keith Pfeil to Chief Operating Officer and Chief Financial Officer, effective as of February 1, 2024.

View on SEC.gov

GLOBUS MEDICAL INC filing history →

Source: SEC EDGAR

accession 0001562762-24-000019

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.